Japan Vaccine Market Report by Product Type, Treatment Type, Technology, Route of Administration, Patient Type, Indication, Distribution Channel, End User, and Region 2025-2033

Description

Japan vaccine market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 2.88% during 2025-2033. The rising prevalence of several chronic diseases, increasing availability of extensive health insurance coverage, and the growing awareness among the masses about the importance of vaccination represent some of the key factors driving the market.

A vaccine is a biological preparation that contains weakened or inactivated forms of pathogens or their components. It is administered to stimulate the immune system and provide immunity against specific diseases. It is rigorously tested for safety to ensure it does not pose significant risks to recipients. It is available in various forms, which include live attenuated, inactivated, subunit, mRNA, and viral vector vaccines. It requires strict temperature control during storage and transportation to maintain efficacy. It is highly effective in preventing a wide range of infectious diseases and often more cost-effective than treating the diseases. It is routinely administered to infants and children to protect them from diseases like measles, mumps, rubella, and pertussis.

Japan Vaccine Market Trends:

The expanding aging population in Japan represents one of the primary factors catalyzing the demand for vaccines to protect against age-related diseases. Additionally, the rising prevalence of several chronic diseases and the growing awareness among the masses about the importance of vaccination are offering a favorable market outlook in the country. Along with this, the country has a well-established distribution network that aids in ensuring vaccines reach the entire population. Apart from this, the increasing participation of Japan in vaccine diplomacy initiatives is bolstering its international standing and creating opportunities for vaccine manufacturers, enhancing production and exports. Furthermore, the expansion of pediatric vaccination programs with a focus on ensuring children receive recommended vaccines is strengthening the growth of the market. Moreover, continuous investments in research and development (R&D) efforts in the field of vaccines are stimulating the market growth. Along with this, rising collaborations with international organizations are facilitating access to a wide range of vaccines and contributing to market growth. Apart from this, the introduction of robust patient education campaigns is disseminating vital information about the benefits of vaccines, further improving acceptance rates. In addition, the availability of extensive health insurance coverage is ensuring the affordability of vaccines for the majority of the population. In addition, the emergence of Japan as a healthcare tourism destination is attracting visitors seeking healthcare services, including vaccinations. Furthermore, the robust epidemiological surveillance systems in Japan facilitate the identification of disease outbreaks and vaccination needs promptly, ensuring a swift response and heightened vaccine demand. Moreover, the expansion of domestic vaccine manufacturing capacity in Japan is ensuring a more self-reliant and resilient supply chain, reducing dependence on imports. Along with this, governing authorities of the country are implementing various incentives and streamlining regulatory processes to encourage vaccine development and manufacturing. These initiatives reduce the barriers to entry for vaccine manufacturers, fostering innovation and competition in the market.

Japan Vaccine Market Segmentation:

Product Type Insights:

Multivalent Vaccine
Monovalent Vaccine

Treatment Type Insights:

Preventive Vaccine
Therapeutic Vaccine

Technology Insights:

Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Others

Route of Administration Insights:

Intramuscular and Subcutaneous Administration
Oral Administration
Others

Patient Type Insights:

Pediatric
Adult

Indication Insights:

Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others

End User Insights:

Hospitals
Clinics
Vaccination Centers
Academic and Research Institutes
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan vaccine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan vaccine market?
What is the breakup of the Japan vaccine market on the basis of product type?
What is the breakup of the Japan vaccine market on the basis of treatment type?
What is the breakup of the Japan vaccine market on the basis of technology?
What is the breakup of the Japan vaccine market on the basis of route of administration?
What is the breakup of the Japan vaccine market on the basis of patient type?
What is the breakup of the Japan vaccine market on the basis of indication?
What is the breakup of the Japan vaccine market on the basis of distribution channel?
What is the breakup of the Japan vaccine market on the basis of end user?
What are the various stages in the value chain of the Japan vaccine market?
What are the key driving factors and challenges in the Japan vaccine?
What is the structure of the Japan vaccine market and who are the key players?
What is the degree of competition in the Japan vaccine market?

Product Code: SR112025A17199

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Vaccine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Vaccine Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Vaccine Market - Breakup by Product Type

6.1 Multivalent Vaccine
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Monovalent Vaccine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Vaccine Market - Breakup by Treatment Type

7.1 Preventive Vaccine
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Therapeutic Vaccine
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Vaccine Market - Breakup by Technology

8.1 Conjugate Vaccines
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Inactivated and Subunit Vaccines
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Live Attenuated Vaccines
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Recombinant Vaccines
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Toxoid Vaccines
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 8.6.2 Market Forecast (2025-2033)

9 Japan Vaccine Market - Breakup by Route of Administration

9.1 Intramuscular and Subcutaneous Administration
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Oral Administration
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Vaccine Market - Breakup by Patient Type

10.1 Pediatric
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Adult
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)

11 Japan Vaccine Market - Breakup by Indication

11.1 Bacterial Diseases
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2019-2024)
- 11.1.3 Market Segmentation
  - 11.1.3.1 Meningococcal Disease
  - 11.1.3.2 Pneumococcal Disease
  - 11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
  - 11.1.3.4 Tuberculosis
  - 11.1.3.5 Haemophilus Influenzae (Hib)
  - 11.1.3.6 Typhoid
  - 11.1.3.7 Others
- 11.1.4 Market Forecast (2025-2033)
11.2 Viral Diseases
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2019-2024)
- 11.2.3 Market Segmentation
  - 11.2.3.1 Hepatitis
  - 11.2.3.2 Influenza
  - 11.2.3.3 Human Papillomavirus (HPV)
  - 11.2.3.4 Measles/Mumps/Rubella (MMR)
  - 11.2.3.5 Rotavirus
  - 11.2.3.6 Herpes Zoster
  - 11.2.3.7 Varicella
  - 11.2.3.8 Japanese Encephalitis
  - 11.2.3.9 Rubella
  - 11.2.3.10 Polio
  - 11.2.3.11 Rabies
  - 11.2.3.12 Dengue
  - 11.2.3.13 Others
- 11.2.4 Market Forecast (2025-2033)

12 Japan Vaccine Market - Breakup by Distribution Channel

12.1 Hospital Pharmacies
- 12.1.1 Overview
- 12.1.2 Historical and Current Market Trends (2019-2024)
- 12.1.3 Market Forecast (2025-2033)
12.2 Retail Pharmacies
- 12.2.1 Overview
- 12.2.2 Historical and Current Market Trends (2019-2024)
- 12.2.3 Market Forecast (2025-2033)
12.3 Institutional Sale
- 12.3.1 Overview
- 12.3.2 Historical and Current Market Trends (2019-2024)
- 12.3.3 Market Forecast (2025-2033)
12.4 Others
- 12.4.1 Overview
- 12.4.2 Historical and Current Market Trends (2019-2024)
- 12.4.3 Market Forecast (2025-2033)

13 Japan Vaccine Market - Breakup by End User

13.1 Hospitals
- 13.1.1 Overview
- 13.1.2 Historical and Current Market Trends (2019-2024)
- 13.1.3 Market Forecast (2025-2033)
13.2 Clinics
- 13.2.1 Overview
- 13.2.2 Historical and Current Market Trends (2019-2024)
- 13.2.3 Market Forecast (2025-2033)
13.3 Vaccination Centers
- 13.3.1 Overview
- 13.3.2 Historical and Current Market Trends (2019-2024)
- 13.3.3 Market Forecast (2025-2033)
13.4 Academic and Research Institutes
- 13.4.1 Overview
- 13.4.2 Historical and Current Market Trends (2019-2024)
- 13.4.3 Market Forecast (2025-2033)
13.5 Others
- 13.5.1 Historical and Current Market Trends (2019-2024)
- 13.5.2 Market Forecast (2025-2033)

14 Japan Vaccine Market - Competitive Landscape

14.1 Overview
14.2 Market Structure
14.3 Market Player Positioning
14.4 Top Winning Strategies
14.5 Competitive Dashboard
14.6 Company Evaluation Quadrant

15 Profiles of Key Players

15.1 Company A
- 15.1.1 Business Overview
- 15.1.2 Product Portfolio
- 15.1.3 Business Strategies
- 15.1.4 SWOT Analysis
- 15.1.5 Major News and Events
15.2 Company B
- 15.2.1 Business Overview
- 15.2.2 Product Portfolio
- 15.2.3 Business Strategies
- 15.2.4 SWOT Analysis
- 15.2.5 Major News and Events
15.3 Company C
- 15.3.1 Business Overview
- 15.3.2 Product Portfolio
- 15.3.3 Business Strategies
- 15.3.4 SWOT Analysis
- 15.3.5 Major News and Events
15.4 Company D
- 15.4.1 Business Overview
- 15.4.2 Product Portfolio
- 15.4.3 Business Strategies
- 15.4.4 SWOT Analysis
- 15.4.5 Major News and Events
15.5 Company E
- 15.5.1 Business Overview
- 15.5.2 Product Portfolio
- 15.5.3 Business Strategies
- 15.5.4 SWOT Analysis
- 15.5.5 Major News and Events

16 Japan Vaccine Market - Industry Analysis

16.1 Drivers, Restraints and Opportunities
- 16.1.1 Overview
- 16.1.2 Drivers
- 16.1.3 Restraints
- 16.1.4 Opportunities
16.2 Porters Five Forces Analysis
- 16.2.1 Overview
- 16.2.2 Bargaining Power of Buyers
- 16.2.3 Bargaining Power of Suppliers
- 16.2.4 Degree of Competition
- 16.2.5 Threat of New Entrants
- 16.2.6 Threat of Substitutes
16.3 Value Chain Analysis